{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:14:23Z","timestamp":1772590463984,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.03.054","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:45:18Z","timestamp":1490661918000},"page":"2351-2357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection"],"prefix":"10.1016","volume":"35","author":[{"given":"Joshua R.","family":"Duncan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5366-2663","authenticated-orcid":false,"given":"Catherine T.","family":"Witkop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryant J.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy A.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.054_b0005","unstructured":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recommendations and reports: morbidity and mortality weekly report Recommendations and reports\/Centers for Disease Control 1996;45:1\u201336."},{"key":"10.1016\/j.vaccine.2017.03.054_b0010","unstructured":"Decline in annual incidence of varicella\u2013selected states, 1990\u20132001. MMWR Morb Mortal Wkly Rep 2003;52:884\u20135."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.03.054_b0015","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2013United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.054_b0020","unstructured":"Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports: morbidity and mortality weekly report Recommendations and reports\/Centers for Disease Control 2007;56:1\u201340."},{"key":"10.1016\/j.vaccine.2017.03.054_b0025","first-page":"174","article-title":"Two-dose varicella vaccination coverage among children aged 7 years\u2013six sentinel sites, United States, 2006\u20132012","volume":"63","author":"Lopez","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.03.054_b0030","doi-asserted-by":"crossref","first-page":"850","DOI":"10.15585\/mmwr.mm6533a4","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years \u2013 United States, 2015","volume":"65","author":"Reagan-Steiner","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.03.054_b0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/315714","article-title":"Varicella mortality: trends before vaccine licensure in the United States, 1970\u20131994","volume":"182","author":"Meyer","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.054_b0040","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4161\/hv.24849","article-title":"Validity of medical record documented varicella-zoster virus among unvaccinated cohorts","volume":"9","author":"Mohanty","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.03.054_b0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/00365540310015719","article-title":"Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age","volume":"35","author":"Parment","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.054_b0050","article-title":"Seroepidemiology of varicella among elementary school children in northern Taiwan","author":"Lin","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2017.03.054_b0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.03.054_b0060","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.vaccine.2009.11.047","article-title":"Report of varicella outbreak in a low vaccination coverage group of otherwise healthy children in Italy: the role of breakthrough and the need of a second dose of vaccine","volume":"28","author":"Tafuri","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.054_b0065","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/INF.0b013e31819c1041","article-title":"An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients\u2013Arkansas, 2006","volume":"28","author":"Gould","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.03.054_b0070","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1086\/522134","article-title":"Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement\u2013Maine, 2006","volume":"197","author":"Parker","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.054_b0075","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.vaccine.2011.01.092","article-title":"Varicella breakthrough infection and vaccine effectiveness in Taiwan","volume":"29","author":"Huang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.054_b0080","doi-asserted-by":"crossref","first-page":"941","DOI":"10.15585\/mmwr.mm6535a4","article-title":"Notes from the field: varicella outbreak associated with riding on a school bus - Muskegon County, Michigan, 2015","volume":"65","author":"Hoch","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.03.054_b0085","doi-asserted-by":"crossref","first-page":"902","DOI":"10.15585\/mmwr.mm6534a4","article-title":"Epidemiology of varicella during the 2-dose varicella vaccination program \u2013 United States, 2005\u20132014","volume":"65","author":"Lopez","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.03.054_b0090","doi-asserted-by":"crossref","unstructured":"Reynolds MA, Kruszon-Moran D, Jumaan A, Schmid DS, McQuillan GM. Varicella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999\u20132004. Public health reports (Washington, DC: 1974) 2010;125:860\u20139.","DOI":"10.1177\/003335491012500613"},{"key":"10.1016\/j.vaccine.2017.03.054_b0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/hv.18444","article-title":"Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage","volume":"8","author":"Plans-Rubio","year":"2012","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.03.054_b0100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/cid\/cir007","article-title":"\u201cHerd immunity\u201d: a rough guide","volume":"52","author":"Fine","year":"2011","journal-title":"Clin Inf Dis: Off Publ Inf Dis Soc Am"},{"key":"10.1016\/j.vaccine.2017.03.054_b0105","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1473-3099(15)00053-5","article-title":"Dangers of vaccine refusal near the herd immunity threshold: a modelling study","volume":"15","author":"Fefferman","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.054_b0110","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/172.3.706","article-title":"The epidemiology of varicella and its complications","volume":"172","author":"Choo","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.054_b0115","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/CVI.05207-11","article-title":"Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay","volume":"18","author":"Binnicker","year":"2011","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2017.03.054_b0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CVI.00561-14","article-title":"Evaluation of a multiplex bead immunoassay for determination of immune status to varicella-zoster virus in medical center students and employees","volume":"22","author":"Loeffelholz","year":"2015","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2017.03.054_b0125","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.amepre.2015.04.019","article-title":"Measles, mumps, and rubella titers in air force recruits: below herd immunity thresholds?","volume":"49","author":"Lewis","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2017.03.054_b0130","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinternmed.2008.513","article-title":"Half- vs full-dose trivalent inactivated influenza vaccine (2004\u20132005): age, dose, and sex effects on immune responses","volume":"168","author":"Engler","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2017.03.054_b0135","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0161-5890(98)00067-4","article-title":"Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens","volume":"35","author":"Luo","year":"1998","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2017.03.054_b0140","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/eji.200636129","article-title":"Virus recognition by specific natural antibodies and complement results in MHC I cross-presentation","volume":"37","author":"Durrbach","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.054_b0145","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10096-013-1836-6","article-title":"New preventive strategy to eliminate measles, mumps and rubella from Europe based on the serological assessment of herd immunity levels in the population","volume":"32","author":"Plans","year":"2013","journal-title":"Eur J Clin Microbiol Inf Dis: Off Publ Eur Soc Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.054_b0150","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/aje\/kwn220","article-title":"Using time-use data to parameterize models for the spread of close-contact infectious diseases","volume":"168","author":"Zagheni","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.03.054_b0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1371\/journal.pmed.0050031","article-title":"Mechanisms of GII.4 norovirus persistence in human populations","volume":"5","author":"Lindesmith","year":"2008","journal-title":"PLos Med"},{"key":"10.1016\/j.vaccine.2017.03.054_b0160","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1128\/JVI.79.22.14017-14030.2005","article-title":"The P domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors","volume":"79","author":"Tan","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.03.054_b0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2567.2011.03516.x","article-title":"A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles","volume":"135","author":"Tamminen","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2017.03.054_b0170","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/COH.0b013e32833d1fca","article-title":"Cofactors that may influence vaccine responses","volume":"5","author":"de Bruyn","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.vaccine.2017.03.054_b0175","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1542\/peds.96.3.584","article-title":"Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines","volume":"96","author":"Christy","year":"1995","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.03.054_b0180","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0264-410X(01)00288-2","article-title":"What are the limits of adjuvanticity?","volume":"20","author":"Del Giudice","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.054_b0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00006454-200101000-00013","article-title":"Immunologic correlates of protection induced by vaccination","volume":"20","author":"Plotkin","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.03.054_b0190","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1086\/529448","article-title":"Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella","volume":"197","author":"Breuer","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.054_b0195","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.03.054_b0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coi.2016.05.014","article-title":"Viral vectors as vaccine platforms: from immunogenicity to impact","volume":"41","author":"Ewer","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2017.03.054_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.05.054","article-title":"A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11\u201312 months","author":"Silfverdal","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.054_b0210","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/338959","article-title":"Persistence of immunity to live attenuated varicella vaccine in healthy adults","volume":"34","author":"Ampofo","year":"2002","journal-title":"Clin Inf Dis: Off Publ Inf Dis Soc Am"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T23:11:07Z","timestamp":1658877067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":42,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17303717"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}